A framework to assess the value of subgroup analyses when the overall treatment effect is significant

International differences in treatment effect: do they really exist and why?†

(2013) Stuart Pocock et al.   EUROPEAN HEART JOURNAL

Treatment Success in Cancer: Industry Compared to Publicly Sponsored Randomized Controlled Trials

(2013) Benjamin Djulbegovic et al.   PLoS One

Bayesian models for subgroup analysis in clinical trials

(2011) Hayley E Jones et al.   Clinical Trials

Subgroup analyses of clinical effectiveness to support health technology assessments

(2011) Marie-Ange Paget et al.   PHARMACEUTICAL STATISTICS

Treatment success in pragmatic randomised controlled trials: a review of trials funded by the UK Health Technology Assessment programme

(2011) Louise Dent et al.   Trials

Inconsistent trial assessments by the National Institute for Health and Clinical Excellence and IQWiG: standards for the performance and interpretation of subgroup analyses are needed

(2010) J. Hasford et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

No inconsistent trial assessments by NICE and IQWiG: different assessment goals may lead to different assessment results regarding subgroup analyses

(2010) Ralf Bender et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Sample size and proportion of Japanese patients in multi-regional trials

(2010) Kimitoshi Ikeda et al.   PHARMACEUTICAL STATISTICS

Treatment Success in CancerNew Cancer Treatment Successes Identified in Phase 3 Randomized Controlled Trials Conducted by the National Cancer Institute–Sponsored Cooperative Oncology Groups, 1955 to 2006

(2008) Benjamin Djulbegovic   ARCHIVES OF INTERNAL MEDICINE